In humans, mutations in IRF2BPL lead to a neurodevelopmental disorder called NEDAMSS (Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and Seizures; OMIM-#618088). Here, IRF2BPL is linked to neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures.